Rabbit Monoclonal Ab (Phage)

Abnova recognizes the importance of rabbit monoclonal antibodies for research, development, and commercialization. Technology accessibility, intellectual property, and higher costs have long hampered the widespread adoption and application of rabbit monoclonal antibodies. Unlocking this barrier is critical to the success of proteomics and the biotech industry where traditional antibody tools such as mouse monoclonal antibodies and rabbit polyclonal antibodies encounter their limitations.

Abnova Rabbit Monoclonal (ARM) technology is an integrated and high throughput platform for the generation of rabbit monoclonal antibodies. This service is available to everyone in the research and in vitro diagnostic community. A wide variety of antigens can be used for rabbit immunization. Rabbit possesses a broader yet non-tolerant immunologic repertoire for antibody development. A non-fusion library is created to screen for antibody clones of the highest affinity and exquisite specificity. The clone is introduced into a proprietary expression vector for transient and scalable antibody production for many downstream applications. Customers can access the rabbit serum for pre-testing, antibody sequencing for antibody engineering, and purified antibodies for application of interest.